These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34398337)

  • 1. Prognostic scores for survival as decisional support for surgery in spinal metastases: a performance assessment systematic review.
    Smeijers S; Depreitere B
    Eur Spine J; 2021 Oct; 30(10):2800-2824. PubMed ID: 34398337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.
    Huang CC; Peng KP; Hsieh HC; Groot OQ; Yen HK; Tsai CC; Karhade AV; Lin YP; Kao YT; Yang JJ; Dai SH; Huang CC; Chen CW; Yen MH; Xiao FR; Lin WH; Verlaan JJ; Schwab JH; Hsu FM; Wong T; Yang RS; Yang SH; Hu MH
    Clin Orthop Relat Res; 2024 Jan; 482(1):143-157. PubMed ID: 37306629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Traditional Prognosis Scoring Systems and Skeletal Oncology Research Group Nomogram for Predicting Survival of Spinal Metastasis Patients Undergoing Surgery.
    Chanplakorn P; Budsayavilaimas C; Jaipanya P; Kraiwattanapong C; Keorochana G; Leelapattana P; Lertudomphonwanit T
    Clin Orthop Surg; 2022 Dec; 14(4):548-556. PubMed ID: 36518924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the SORG algorithm generalize to a contemporary cohort of patients with spinal metastases on external validation?
    Bongers MER; Karhade AV; Villavieja J; Groot OQ; Bilsky MH; Laufer I; Schwab JH
    Spine J; 2020 Oct; 20(10):1646-1652. PubMed ID: 32428674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the SORG machine learning algorithms for predicting 90-day and 1-year survival of patients with lung cancer-derived spine metastases: a recent bi-center cohort from China.
    Zhong G; Cheng S; Zhou M; Xie J; Xu Z; Lai H; Yan Y; Xie Z; Zhou J; Xie X; Zhou C; Zhang Y
    Spine J; 2023 May; 23(5):731-738. PubMed ID: 36706921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of the SORG 90-day and 1-year machine learning algorithms for survival in spinal metastatic disease.
    Karhade AV; Ahmed AK; Pennington Z; Chara A; Schilling A; Thio QCBS; Ogink PT; Sciubba DM; Schwab JH
    Spine J; 2020 Jan; 20(1):14-21. PubMed ID: 31505303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Novel Survival Prediction Model in Patients With Spinal Metastasis From Non-small Cell Lung Cancer.
    Yang M; Xu W; Liu T; Yang X; Wang P; Wu S; Wei H; Zhao J; Yang C; Xiao J
    Spine (Phila Pa 1976); 2019 Feb; 44(4):246-257. PubMed ID: 30059487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated external validation of the SORG machine learning algorithms for prediction of ninety-day and one-year mortality after surgery for spinal metastasis.
    Shah AA; Karhade AV; Park HY; Sheppard WL; Macyszyn LJ; Everson RG; Shamie AN; Park DY; Schwab JH; Hornicek FJ
    Spine J; 2021 Oct; 21(10):1679-1686. PubMed ID: 33798728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive ability of routinely collected laboratory markers for surgically treated spinal metastases: a retrospective single institution study.
    Li Z; Huang L; Guo B; Zhang P; Wang J; Wang X; Yao W
    BMC Cancer; 2022 Nov; 22(1):1231. PubMed ID: 36447178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SORG algorithm to predict 3- and 12-month survival in metastatic spinal disease: a cross-sectional population-based retrospective study.
    Zegarek G; Tessitore E; Chaboudez E; Nouri A; Schaller K; Gondar R
    Acta Neurochir (Wien); 2022 Oct; 164(10):2627-2635. PubMed ID: 35925406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis.
    Luksanapruksa P; Buchowski JM; Hotchkiss W; Tongsai S; Wilartratsami S; Chotivichit A
    Spine J; 2017 May; 17(5):689-708. PubMed ID: 27988342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of the accuracy of the New England Spinal Metastasis Score (NESMS) to legacy scoring systems in prognosticating outcomes following treatment of spinal metastases.
    Schoenfeld AJ; Ferrone ML; Blucher JA; Agaronnik N; Nguyen L; Tobert DG; Balboni TA; Schwab JH; Shin JH; Sciubba DM; Harris MB
    Spine J; 2022 Jan; 22(1):39-48. PubMed ID: 33741509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International external validation of the SORG machine learning algorithms for predicting 90-day and one-year survival of patients with spine metastases using a Taiwanese cohort.
    Yang JJ; Chen CW; Fourman MS; Bongers MER; Karhade AV; Groot OQ; Lin WH; Yen HK; Huang PH; Yang SH; Schwab JH; Hu MH
    Spine J; 2021 Oct; 21(10):1670-1678. PubMed ID: 33545371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SORG nomogram accurately predicts 3- and 12-months survival for operable spine metastatic disease: External validation.
    Paulino Pereira NR; Mclaughlin L; Janssen SJ; van Dijk CN; Bramer JAM; Laufer I; Bilsky MH; Schwab JH
    J Surg Oncol; 2017 Jun; 115(8):1019-1027. PubMed ID: 28346699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting survival for metastatic spine disease: a comparison of nine scoring systems.
    Ahmed AK; Goodwin CR; Heravi A; Kim R; Abu-Bonsrah N; Sankey E; Kerekes D; De la Garza Ramos R; Schwab J; Sciubba DM
    Spine J; 2018 Oct; 18(10):1804-1814. PubMed ID: 29567516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Nomogram for Survival Prediction of Patients with Spinal Metastasis From Prostate Cancer.
    Liu Y; Li L; Jiang D; Yang M; Gao X; Lv K; Xu W; Wei H; Wan W; Xiao J
    Spine (Phila Pa 1976); 2021 Mar; 46(6):E364-E373. PubMed ID: 33620180
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.